Abdi S. Prevention and management of complex regional pain syndrome in adults. UpToDate [serial online]. Waltham, MA: UpToDate; reviewed October 2012.
Ackermans L, Duits A, van der Linden C, et al. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain. 2011;134(Pt 3):832-844.
Alonso P, Cuadras D, Gabriels L, et al. Deep brain stimulation for obsessive-compulsive disorder: a meta- analysis of treatment outcome and predictors of response. PLoS One. 2015;10(7):e0133591.
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Obsessive-Compulsive Disorder. [Psychiatryonline Web site]. 2010. Available at: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/ocd.pdf. Accessed November 01, 2024.
Appleby BS, Duggan PS, Regenberg A, et al. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Mov Disord. 2007;22(12):1722-1728.
Baldermann JC, Schuller T, Huys D, et al. Deep brain stimulation for tourette-syndrome: a systematic review and meta-analysis. Brain Stimul. 2016;9(2):296-304.
Bergfeld IO, Mantione M, Hoogendoorn ML, et al. Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):456-464.
Bhidayasiri R, Fahn S, Weiner WJ, et al. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(5):463-469.
Bhidayasiri R, Jitkritsadakul O, Friedman JH, et al. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm. J Neurol Sci. 2018;389:67-75.
BlueCross BlueShield Association (BCBSA) Technology Evaluation Center (TEC). Bilateral DBS of the subthalamic nucleus or the globus pallidus interna for treatment of advanced Parkinson's disease [technology assessment]. Assessment Program Volume 16, No. 16. February 2002.
BlueCross BlueShield Association (BCBSA) Technology Evaluation Center (TEC). Deep brain stimulation of the thalamus for tremor. TEC Assessment. 1997;Volume 12:Tab 20.
Boland D, Stacy, M. The economic and quality of life burden associated with Parkinson's disease: A focus on symptoms. Am J Manag Care. 2012;18(7):168-175.
Borghs SS, de la Loge CC, Cramer JJ. Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures. Epilepsy Behav. 2012;23(3):230-4.
Bouwens van der Vlis TAM, Schijns OEMG, Schaper FLWVJ, et al. Deep brain stimulation of the anterior nucleus of the thalamus for drug-resistant epilepsy. Neurosurg Rev. 2019;42(2): 287-296.
Brandmeir NJ, Murray A, Cheyuo C, et al. Deep Brain Stimulation for Multiple Sclerosis Tremor: A Meta-Analysis. Neuromodulation. 2020;23(4):463-468.
|
Broggi G, Franzini A, Leone M, Bussone G. Update on neurosurgical treatment of chronic trigeminal autonomic cephalagias and atypical facial pain with deep brain stimulation of posterior hypothalmus: results and comments. Neurol Sci. 2007;28 (suppl 2):S138- S145.
Bussone G, Franzini A, Proietti Cecchini A, et al. Deep brain stimulation in craniofacial pain: seven years' experience. Neurol Sci. 2007;28(Suppl 2):S146-149.
Canadian Movement Disorder Group (CMDG). Parkinson's "plus" syndromes or the multi system degenerations. [CMDG Web site]. Available at: http://www.cmdg.org/Movement_/Parkinsons_Plus/parkinsons_plus.htm. Accessed November 1, 2024.
Capelle HH, Simpson RK Jr, Kronenbuerger M, et al. Long-term deep brain stimulation in elderly patients with cardiac pacemakers. J Neurosurg. 2005; 102(1):53-59.
Carpenter LL, Friehs GM, Tyrka AR, et al. Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Med Health R I. 2006;89(4):137, 140-141.
Centers for Medicare & Medicaid Services (CMS). CMS Manual System. Pub 100-04: Medicare claims processing. Transmittal 128.50: Deep brain stimulation for essential tremor and Parkinson's disease. [CMS Web site]. 03/26/04. Available at: http://www.cms.hhs.gov/transmittals/downloads/R128CP.pdf. Accessed November 01, 2024.
Centers for Medicare & Medicaid Services (CMS). National Coverage Determination (NCD). 160.24: Deep brain stimulation for essential tremor and Parkinson’s disease. [CMS Web site]. 04/01/03. Available at: http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=279&ncdver=1&bc=AgAAgAAAAAAA&. Accessed November 01, 2024.
ClinicalTrials.gov. Controlled trial of deep brain stimulation in early patients with parkinson's disease [Clinical trials.gov Web site]. Available at: https://clinicaltrials.gov/ct2/show/record/NCT00354133. Accessed November 01, 2024.
Collins TR. Brain stimulation device found to reduce seizures in randomized trial. Neurology Today. October 21, 2010. pg.14.
Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease: a meta-analysis. Neuropsychol Rev. 2015;25(4):439-454.
Crowell AL, Riva-Posse P, Holtzheimer PE, et al. Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression. Am J Psychiatry. 2019;176(11):949-956.
Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14(9):952-970.
Cukiert A, Cukiert CM, Burattini JA, et al. Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy: A prospective, controlled, randomized, double-blind study. Epilepsia. 2017;58(10):1728-1733.
Dalvi A, Bloomfield SM. Parkinson-plus syndromes. [eMedicine Web site]. 03/07/2023. Available at: http://emedicine.medscape.com/article/1154074-overview. Accessed November 01, 2024.
Damier P, Thobois S, Witjas T, et al. French Stimulation for Tardive Dyskinesia (STARDYS) Study Group. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry. 2007;64(2):170-176.
de Koning PP, Figee M, van den Munckhof P, Schuurmann PR, Denys D. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiatry Rep. 2011;13(4):274-282.
Deer TR, Falowski S, Arle JE, et al. A Systematic Literature Review of Brain Neurostimulation Therapies for the Treatment of Pain. Pain Med. 2020;21(7):1415-1420.
Dembek TA, Reker P, Visser-Vandewalle V, et al. Directional DBS increases side-effect thresholds-A prospective, double-blind trial. Mov Disord. 2017;32(10):1380-1388.
Denys D, de Koning PP. Deep brain stimulation for treatment of obsessive-compulsive disorder. [UpToDate Web site]. 05/24/2024. Available at:
http://www.uptodate.com/contents/deep-brain-stimulation-for-treatment-of-obsessive-compulsive-disorder?source=search_result&search=Deep+brain+stimulation+for+treatment+of+obsessive-compulsive+disorder&selectedTitle=1~104#H1391040 [via subscription only]. Accessed November 01, 2024.
Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67(10):1061-1068.
Deuschl G, Schade-Brittinger C, Krack P, et al. German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896-908.
Dougherty DD, Rezai AR, Carpenter LL, et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry. 2015;78(4):240-248.
Eitan R, Lerer B. Nonpharmacological, somatic treatments of depression: Electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci. 2006;8(2):241-258.
Ekbom K, Waldenlind E. Cluster headache: The history of the Cluster Club and a review of recent clinical research. Funct Neurol. 2004;19(2):73-81.
Enriquez J. FDA clears St. Jude's brain implant for Parkinson's disease. [MED Device Online Web site]. 06/16/2015. Available at: https://www.meddeviceonline.com/doc/fda-clears-st-jude-s-brain-implant-for-parkinson-s-disease-0001. Accessed November 01, 2024.
Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908.
Fisher R, Salanova V, Witt T, et al; SANTE Study Group. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908.
Fontaine D, Lazorthes Y, Mertens P, et al. Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain. 2010;11(1):23-31.
Foote KD, Seignourel P, Fernandez HH, et al. Dual electrode thalamic deep brain stimulation for the treatment of posttraumatic and multiple sclerosis tremor. Neurosurgery. 2006;58(4 Suppl 2):ONS-280-285; discussion ONS-285-286.
Fountas KN, Kapsalaki E, Hadjigeorgiou G. Cerebellar stimulation in the management of medically intractable epilepsy: A systematic and critical review. Neurosurg Focus. 2010;29(2):E8.
Fraint A, Pal G. Deep brain stimulation in Tourette's syndrome. Front Neurol. 2015;6:170.
Franzini A, Ferroli P, Leone M, et al. Hypothalamus deep brain stimulation for the treatment of chronic cluster headaches: a series report. Neuromodulation. 2004;7(1):1-8.
Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery. 2003;52(5):1095-1101.
Fundament T, Eldridge PR, Green AL, et al. Deep brain stimulation for Parkinson’s disease with early motor complications: a UK cost-effectiveness analysis. PLoS One. 2016;11(7):e0159340.
Georgiopoulos M, Katsakiori P, Kefalopoulou Z, et al. Vegetative state and minimally conscious state: A review of the therapeutic interventions. Stereotact Funct Neurosurg. 2010;88(4):199-207.
Goodman JH. Brain stimulation as a therapy for epilepsy. Adv Exp Med Biol. 2004;548:239-247.
Goodman WK, Foote KD, Greenberg BD, et al. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010;67(6):535-542.
Gratwicke J, Zrinzo L, Kahan J, et al. Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial. Brain Stimul. 2020;13(4):1031-1039.
Greenberg BC, Gabriels LA, Malone DA Jr, et al. Deep brain stimulation of the ventral internal capsule/ ventral striatuim for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15(1):64-79. [Epub May 20, 2008].
Gruber D, Sudmeyer M, Deuschl G, et al. Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial. Brain Stimul. 2018;11(6):1368-1377.
Gruber D, Trottenberg T, Kivi A, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology. 2009;73(1):53-58.
Halbig TD, Gruber D, Kopp UA, et al. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. J Neurol Neurosurg Psychiatry. 2005;76(12):1713-16.
Hallett M, Evinger C, Jankovic J, Stacy M; BEBRF International Workshop. Update on blepharospasm: Report from the BEBRF International Workshop. Neurology. 2008;71(16):1275-1282.
Halpern CH, Torres N, Hurtig HI, et al. Expanding applications of deep brain stimulation: A potential therapeutic role in obesity and addiction management. Acta Neurochir (Wien). 2011;153(12):2293-2306.
Halpern CH, Wolf JA, Bale TL, et al. Deep brain stimulation in the treatment of obesity. J Neurosurg. 2008;109(4):625-634.
Hamani C, Pilitsis J, Rughani AI, et al. Deep brain stimulation for obsessive-compulsive disorder: systematic review and evidence-based guideline sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and endorsed by the CNS and American Association of Neurological Surgeons. Neurosurgery. 2014;75(4):327-333; quiz 333.
Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry. 2008;79(6):694-699.
Hitti FL, Yang AI, Cristancho MA, et al. Deep Brain Stimulation Is Effective for Treatment-Resistant Depression: A Meta-Analysis and Meta-Regression. J Clin Med. Aug 30 2020;9(9).
Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150-8.
Holtzheimer PE 3rd, Nemeroff CB. Advances in the treatment of depression. NeuroRx. 2006;3(1):42-56.
Huff W, Lenartz D, Schormann M, et al. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg. 2010;112(2):137-143.
International Headache Society. International Classification of Headache Disorders. 2018. Available at: https://www.ichd-3.org. Accessed July 20, 2022.
Jahanshahi M, Ardouin CM, Brown RG, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain. 2000;123(Pt 6):1142-54.
Jankovic J. Complications and limitations of drug therapy for Parkinson's disease. Neurology. 2000;55(12 Suppl 6):S2-S6.
Kang GA, Heath S, Rothlind J, Starr PA. Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease. J Neurol Neurosurg Psychiatry. 2011;82(3):272-277.
Katayama Y, Kasai M, Oshima H, et al. Double blinded evaluation of the effects of pallidal and subthalamic nucleus stimulation on daytime activity in advanced Parkinson's disease. Parkinsonism Relat Disord. 2000;7(1):35-40.
Kefalopoulou Z, Zrinzo L, Jahanshahi M, et al. Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial. Lancet Neurol. 2015;14(6):595-605.
Kennedy SH, Milev R, Giacobbe P, et al; Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009;117 Suppl 1:S44-S53.
Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009;117 Suppl 1:S44-S53.
Kieburtz K, Hubble J. Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trials. Neurology. 2000;55(11 Suppl 4):S42-S50.
Kim SH, Lim SC, Kim J, et al. Long-term follow-up of anterior thalamic deep brain stimulation in epilepsy: A 11- year, single center experience. Seizure. 2017;52:154-161.
Kisely S, Hall K, Siskind D, et al. Deep brain stimulation for obsessive-compulsive disorder: a systematic review and meta-analysis. Psychol Med. 2014;44(16):3533-3542.
Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(suppl 14):S290-S304.
Koy A, Hellmich M, Pauls KA, et al. Effects of deep brain stimulation in dyskinetic cerebral palsy: A meta-analysis. Mov Disord. 2013;28(5):647-654.
Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry. 2001;70(4):464-470.
Kumar R, Krack P, Pollak P. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 1999;341(13):1003-1004.
Kumar R, Lang AE, Rodriguez-Oroz MC, et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology. 2000;55(12 Suppl 6):S34-S39.
Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology. 1999;53(3):561-566.
Kupsch A, Benecke R, Muller J, et al. Deep-Brain Stimulation for Dystonia Study Group. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006;355(19):1978-1990.
Kwan PP, Arzimanoglou AA, Berg AA, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-77.
Landau WM, Perlmutter JS. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 1999;341(13):1004.
Leone M. Chronic cluster headache: New and emerging treatment options. Curr Pain Headache Rep. 2004;8(5):347-352.
Leone M, May A, Franzini A, et al. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia. 2004;24(11):934-937.
Li MCH, Cook MJ. Deep brain stimulation for drug-resistant epilepsy. Epilepsia. 2018;59(2):273-290.
Lipsman N, Woodside DB, Giacobbe P, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: A phase 1 pilot trial. Lancet. 2013;381(9875):1361-1370.
Lopiano L, Rizzone M, Perozzo P, et al. Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results. Neurol Sci. 2001;22(1):67-68.
Lozano AM. Deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord. 2001;7(3):199-203.
Luigjes J, van den Brink W, Feenstra M, et al. Deep brain stimulation in addiction: A review of potential brain targets. Mol Psychiatry. 2012;17(6):572-583.
Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20) 2121- 2134.
Mar-Barrutia L, Real E, Segalas C, et al. Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years. World J Psychiatry. 2021;11(9):659-680.
Marks WA, Honeycutt J, Acosta F Jr, et al. Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus. Mov Disord. 2011;26(9):1748-1751.
Martinez-Ramirez DD, Jimenez-Shahed JJ, Leckman JJ, et al. Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA Neurol. 2018;75(3):353-359.
McKhann GM 2nd. Novel surgical treatments for epilepsy. Curr Neurol Neurosci Rep. 2004;4(4):335-339.
Miyawaki E, Perlmutter JS, Troster AI, Videen TO, Koller WC. The behavioral complications of pallidal stimulation: a case report. Brain Cogn. 2000;42(3):417-434.
Molinuevo JL, Valldeoriola F, Tolosa E, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol. 2000;57(7):983-988.
Morishita T, Fayad SM, Higuchi MA, et al. Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics. 2014;11(3):475-484.
Moro E, LeReun C, Krauss JK, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. Eur J Neurol. 2017;24(4):552-560.
Moro E, Scerrati M, Romito LM, et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology. 1999;53(1):85-90.
Morrell M. Brain stimulation for epilepsy: Can scheduled or responsive neurostimulation stop seizures? Curr Opin Neurol. 2006;19(2):164-168.
Morrison CE, Borod JC, Brin MF, et al. A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: development, feasibility, and preliminary data. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13(3):204-219.
Mosley PE, Marsh R, Carter A. Deep brain stimulation for depression: Scientific issues and future directions. Aust N Z J Psychiatry. 2015;49(11):967-978.
Muller-Vahl KR, Cath DC, Cavanna AE, et al; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: Deep brain stimulation. Eur Child Adolesc Psychiatry. 2011;20(4):209-217.
Muller-Vahl KR, Cath DC, Cavanna AE, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry. 2011;20(4):209-217.
Naesstrom M, Blomstedt P, Bodlund O. A systematic review of psychiatric indications for deep brain stimulation, with focus on major depressive and obsessive-compulsive disorder. Nord J Psychiatry. 2016;70(7):483-491.
National Institute for Clinical Excellence (NICE). Interventional Procedure Guidance 19: Deep brain stimulation for Parkinson’s disease. [NICE Web site]. November 2003. Available at: https://www.nice.org.uk/guidance/ipg19. Accessed November 01, 2024.
National Institute for Clinical Excellence (NICE). Interventional Procedure Guidance 188: Deep brain stimulation for tremor and dystonia (excluding Parkinson’s disease). [NICE Web site]. August 2006. Available at: http://www.nice.org.uk/guidance/IPG188/resources. Accessed November 01, 2024.
Nutt JG, Anderson VC, Peacock JH, Hammerstad JP, Burchiel KJ. DBS and diathermy interaction induces severe CNS damage. Neurology. 2001;56(10):1384-1386.
Obeso JA, Rodriguez-Oroz MC, Chana P, et al. The evolution and origin of motor complications in Parkinson's disease. Neurology. 2000;55(11 suppl 4):S13-S20.
Obeso JA, Rodriguez-Oroz MC, Rodriguez M, et al. Pathophysiologic basis of surgery for Parkinson's disease. Neurology. 2000;55(12 suppl 6):S7-S12.
Olanow CW, Brin MF, Obeso JA. The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology. 2000;55(12 suppl 6):S60-S66.
Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology. 2001;56(11 suppl 5):S1-S88.
Pansaon Piedad JC, Rickards HE, Cavanna AE. What patients with Gilles de la Tourette syndrome should be treated with deep brain stimulation and what is the best target? Neurosurgery. 2012;71(1):173-192.
Parkin AJ, Java RI. Deterioration of frontal lobe function in normal aging: influences of fluid intelligence versus perceptual speed. Neuropsychology. 1999;13(4):539-545.
Pahwa R, Factor SA, Lyons KE, et al. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):983-995.
Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104(4):506-512.
Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, et al. Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. J Neurol. 2014;261(11):2051-2060.
Piedad JC, Rickards HE, Cavanna AE. What patients with Gilles de la Tourette syndrome should be treated with deep brain stimulation and what is the best target? Neurosurgery. 2012;71(1):173-192.
Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology. 2000;55(3):411-418.
Pollo C, Kaelin-Lang A, Oertel MF, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014;137(Pt 7):2015-2026.
Porta M, Brambilla A, Cavanna AE, et al. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: Two-year outcome. Neurology. 2009;73(17):1375-1380.
Pouclet-Courtemanche H, Rouaud T, Thobois S, et al. Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia. Neurology. 2016;86(7):651-659.
Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906.
Putzke JD, Uitti RJ, Obwegeser AA, Wszolek ZK, Wharen RE. Bilateral thalamic deep brain stimulation: midline tremor control. J Neurol Neurosurg Psychiatry. 2005;76(5):684-690.
Rabins P, Appleby BS, Brandt J, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry. 2009;66(9):931-937.
Rasche D, Rinaldi PC, Young RF, et al. Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus. 2006;21(6):E8.
Raviv N, Staudt MD, Rock AK, et al. A Systematic Review of Deep Brain Stimulation Targets for Obsessive Compulsive Disorder. Neurosurgery. 2020;87(6):1098-1110.
Rebelo P, Green AL, Aziz TZ, et al. Thalamic Directional Deep Brain Stimulation for tremor: Spend less, get more. Brain Stimul. 2018;11(3):600-606.
Rizzone M, Lanotte M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. J Neurol Neurosurg Psychiatry. 2001;71(2):215-219.
Robertson LT, Horak FB, Anderson VC, Burchiel KJ, Hammerstad JP. Assessments of axial motor control during deep brain stimulation in parkinsonian patients. Neurosurgery. 2001;48(3):544-552.
Rodriguez-Oroz MC, Gorospe A, Guridi J, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology. 2000;55(12 suppl 6):S45-S51.
Rodrigues, FB, Duarte, GG, Prescott, DD, Ferreira, JJ, Costa, JJ. Deep brain stimulation for dystonia. Cochrane Database Syst Rev. 2019 Jan 11;1:CD012405.
Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary. Neurosurgery. 2018; 82(6):753-756.
Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain. 2000;123(pt 10):2091-2108.
Sako W, Miyazaki Y, Izumi Y, et al. Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2014;85(9):982-986.
Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84(10):1017-1025.
Schrock LE, Mink JW, Woods DW, et al. Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord. 2015;30(4):448-471.
Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: A review of the literature. J Commun Disord. 2000;33(1):59-88.
Schuepbach WM, Rau J, Knudsenet K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610-622.
Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68(4):267-271.
Schuurman PR, Bosch DA, Merkus MP, et al. Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov Disord. 2008;23(8):1146-1153.
Scotto di Luzio AE, Ammannati F, Marini P, Sorbi S, Mennonna P. Which target for DBS in Parkinson's disease? Subthalamic nucleus versus globus pallidus internus. Neurol Sci. 2001;22(1):87-88.
Senatus PB, McClelland S, Ferris AD, et al. Implantation of bilateral deep brain stimulators in patients with Parkinson disease and preexisting cardiac pacemakers. Report of two cases. J Neurosurg. 2004;101(6):1073-1077.
Servello D, Zekaj E, Saleh C, et al. Sixteen years of deep brain stimulation in Tourette's Syndrome: a critical review. J Neurosurg Sci. 2016;60(2):218-229.
Sirven JI. Evaluation and management of drug-resistant epilepsy. Up to Date.[UpToDate Web site]. 06/07/2021. Available at: http://www.uptodate.com/home/index.html. [via subscription only]. Accessed July 20, 2022.
Sherry DD. Complex regional pain syndrome in children. UpToDate [serial online]. Waltham, MA: UpToDate; updated 03/22/2016.
Sprengers M, Vonck K, Carrette E, et al. Deep brain and cortical stimulation for epilepsy. Cochrane Database Syst Rev. 2017;7:CD008497.
Starr PA, Vitek JL, DeLong M, Bakay RA. Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery. 1999;44(2):303-314.
Staudt MD, Pouratian N, Miller JP, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Deep Brain Stimulations for Obsessive-Compulsive Disorder: Update of the 2014 Guidelines. Neurosurgery. 2021;88(4):710-712.
Stebbins GT, Gabrieli JD, Shannon KM, Penn RD, Goetz CG. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cogn. 2000;42(3):348-363.
Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144-51.
Steigerwald F, Muller L, Johannes S, et al. Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device. Mov Disord. 2016;31(8):1240-1243.
Straits-Tröster K, Fields JA, Wilkinson SB, et al. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain Cogn. 2000;42(3):399-416.
Tan ZG, Zhou Q, Huang T, et al. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials. Clin Interv Aging. 2016;11:777-786.
Temel Y, Visser-Vandewalle V. Surgery in Tourette syndrome. Mov Disord. 2004;19(1):3-14.
Tekriwal A, Baltuch G. Deep brain stimulation: expanding applications. Neurol Med Chir (Tokyo). 2015;55(12):861–877.
Timmermann L, Deuschl G, Fogel W, et al; Deep Brain Stimulation Association. Deep brain stimulation for tremor in multiple sclerosis: Consensus recommendations of the German Deep Brain Stimulation Association. Nervenarzt. 2009;80(6):673-677.
Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis. Neurology. 2001;57(4):663-671.
Trepanier LL, Kumar R, Lozano AM, Lang AE, Saint-Cyr JA. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn. 2000;42(3):324-347.
Troster AI, Meador KJ, Irwin CP, Fisher RS, Group SS. Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy. Seizure. 2017;45:133-141.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). H020007: Medtronic Activa® Dystonia Therapy. Humanitarian device exemption (HDE) application approval. [FDA Web site]. 04/15/03. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf2/H020007a.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration. Center for Devices and Radiological Health (CDRH). Medtronic® Activa™ Dystonia Therapy. Summary of Safety and Probable Benefit. 2003. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf2/H020007b.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). Medtronic® Activa™ Tremor Control System. Premarket approval letter. [FDA Web site]. 07/31/97. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/p960009.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). Medtronic Reclaim® DBS for OCD. Summary of Safety and Probable Benefit. [FDA Web site]. 03/21/05. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf5/H050003b.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). P960009/S7: Medtronic Activa® Parkinson's Control System. Premarket approval letter. [FDA Web site]. 01/14/02. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/p960009S7a.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Medtronic DBS Therapy For Epilepsy. Premarket Approval Letter. [FDA Web site]. 04/27/2018. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf/P960009S219A.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Medtronic DBS Therapy For Epilepsy. Summary of safety and effective data (SSED). [FDA Web site]. 04/27/2018. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf/P960009S219B.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Listing of CDRH Humanitarian use devices. [FDA Web site]. Page last updated 5/29/2024. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfHDE/HDEInformation.cfm. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Medtronic DBS therapy for Parkinson's disease. Premarket Approval (PMA) Database. [FDA Website]. 11/17/2015. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P960009S229. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. St. Jude Brio Neurostimulation System. Premarket approval letter, summary of safety and effectiveness, labeling. [FDA Web site]. 01/16/17. Available at:https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140009B.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). H050003: Reclaim™ Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD) Therapy. Humanitarian device exemption (HDE) application approval. [FDA Web site]. 05/03/2019. Available at: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/HDEApprovals/ucm161827.htm. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Brio Neurostimulation System. Premarket Approval Letter. [FDA Web site]. 06/12/2015. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140009A.pdf. Accessed November 01, 2024.
U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health. Brio Stimulator, electrical, implanted, for parkinsonian tremor. St. Jude Neurostimulation System. Summary of safety and effectiveness. [FDA Web site]. 06/12/15. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf14/P140009B.pdf. Accessed November 01, 2024.
Van Horn G, Schiess MC, Soukup VM. Subthalamic deep brain stimulation: neurobehavioral concerns. Arch Neurol. 2001;58(8):1205-1206.
Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005;352(5):459-467.
Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007;6(3):223-229.
Vingerhoets G, van der Linden C, Lannoo E, et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;66(3):297-294.
Visser-Vandewalle V, Temel Y, Boon P, et al. Chronic bilateral thalamic stimulation: A new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg. 2003;99(6):1094-1100.
Volkmann J, Allert N, Voges J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56(4):548-551.
Volkmann J, Mueller J, Deuschl G, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014;13(9):875-884.
Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11(12):1029-1038.
Wang JW, Zhang YQ, Zhang XH, et al. Cognitive and psychiatric effects of STN versus GPi deep brain stimulation in Parkinson's disease: a meta-analysis of randomized controlled trials. PLoS One. 2016;11(6):e0156721.
Washington State Department of Labor and Industries. Work-related complex regional pain syndrome (CRPS): Diagnosis and treatment. Olympia, WA: Washington State Department of Labor and Industries; October 1, 2011.
Wehmeyer L, Schuller T, Kiess J, et al. Target-Specific Effects of Deep Brain Stimulation for Tourette Syndrome: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:769275.
Welter MM, Houeto JJ, Thobois SS, et al. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16(8):610-619.
Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581-591.
Wong JK, Cauraugh JH, Ho KWD et al. STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis. Parkinsonism Relat. Disord. 2019;58:56-62.
Wu H, Van Dyck-Lippens PJ, Santegoeds R, et al. Deep-brain stimulation for anorexia nervosa. World Neurosurg. 2013;80(3-4):S29.e1-e10.
Wu Y, Mo J, Sui L, et al. Deep Brain Stimulation in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis on Efficacy and Safety. Front Neurosci. 2021;15:655412.
Xie CL, Shao B, Chen J, et al. Effects of neurostimulation for advanced Parkinson's disease patients on motor symptoms: A multiple-treatments meta-analysas of randomized controlled trials. Sci Rep. 2016;6:25285.
Xu F, Ma W, Huang Y, et al. Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials. Neuropsychiatr Dis Treat. 2016;12:1435-1444.
Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2011;77(19):1752-5.
Zesiewicz TA, Elbe R, Louis ED, et al. Practice parameters: Therapies for essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2005;64(12):2008-2020.
Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology.2010;74(11):924-931.